.
.
.
.
Coronavirus

EU to fast track approval of variant-modified COVID-19 vaccines - paper

Published: Updated:

The European Union will fast track approvals of coronavirus vaccines adapted to combat mutations, the bloc’s Health Commissioner Stella Kyriakides said in a newspaper interview on Sunday.

“We have now decided that a vaccine that has been improved by the manufacturer on the basis of the previous vaccine to combat new mutations no longer has to go through the entire approval process,” she told Bavaria’s Augsburger Allgemeine.

For more coronavirus news, visit our dedicated page.

“So it will be faster to have suitable vaccines available without compromising on safety.”

The European Commission has come under fire from EU member states over delays to deliveries of vaccines which has seen the bloc lag behind countries such as Britain, a former member, and the US.

Kyriakides is a member of a new task force, led by Industry Commissioner Thierry Breton, to eliminate bottlenecks in production plants and adjust output to new variants.

While vaccinations in the first quarter of 2021 have started slowly, the second quarter would see a pick-up and by the end of September the EU expects to have received sufficient doses from licensed producers to cover over 70 percent of its population, Kyriakides said.

She also reiterated the Commission view that closing borders was not an effective weapon against infections.

For all the latest headlines follow our Google News channel online or via the app.

“I think it is wrong for us to return to a Europe with closed borders, as in March 2020,” she said.

Germany will enforce entry bans on travelers from the Czech Republic and Austria’s Tyrol region from Sunday to prevent the spread of new variants.

Read more:

France debates third COVID-19 lockdown as new variants spread

EU COVID-19 deaths top 500,000, worst-hit states improving

Delay in vaccinations could cost EU economy $108 bln, says study